Science Corporation, the brain-tech startup founded by former Neuralink president Max Hodak, raised $400 million in a Series D round backed by Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech. A person familiar with the deal told TechCrunch the round values the company at $3.5 billion. Hodak also announced at TechCrunch Disrupt that the company's PRIMA vision-restoring implant is now being trialled for Stargardt's disease in addition to macular degeneration.
techcrunch.com
· 2026-11-17
Science Corporation CEO Max Hodak announced the company implanted its PRIMA vision-restoring chip into its first patient with Stargardt disease, an inherited condition that gradually destroys central vision. The implant was performed in May at Sydney Eye Hospital in Australia as part of an ongoing clinical trial, extending use of a device already sold in Europe for geographic atrophy.
techcrunch.com
· 2026-10-13
Science Corporation CEO Max Hodak will speak at TechCrunch Disrupt 2026's Beyond Screens session about his company's biohybrid brain-computer interface, for which it has recruited a leading neurobiologist to run the first U.S. human trials. Hodak, a Neuralink co-founder, argues that keyboards and screens will eventually give way to interfaces built directly around brain activity.
techcrunch.com
· 2026-09-16
Max Hodak, CEO of Science Corporation and Neuralink co-founder, will speak at TechCrunch Disrupt 2026 in San Francisco about his company's biohybrid brain-computer interface, which has recruited a leading neurobiologist to run its first U.S. human trials. In his Disrupt Stage session, Hodak will argue that computing is moving beyond screens toward interfaces built directly on brain-computer interaction.
techcrunch.com
· 2026-09-16